Magnus Lindskog

Real-world drivers of treatment choices in synchronous metastatic renal cell carcinoma

Almdalal, Tarik; Fahlen, Maja; Harmenberg, Ulrika; Ljungberg, Borje et al.

Part of BJUI Compass, 2026

• DOI for Real-world drivers of treatment choices in synchronous metastatic renal cell carcinoma
• Download full text (pdf) of Real-world drivers of treatment choices in synchronous metastatic renal cell carcinoma

Baseline laboratory values and metastatic burden predict survival in addition to IMDC risk in real-world renal cell carcinoma patients treated with ipilimumab-nivolumab

Kheir, Alaa; Johannsdottir, Berglind; Gronn-Weiss, Alexandra; Liu, Lisa L. et al.

Part of Acta Oncologica, p. 1355-1364, 2025

• DOI for Baseline laboratory values and metastatic burden predict survival in addition to IMDC risk in real-world renal cell carcinoma patients treated with ipilimumab-nivolumab
• Download full text (pdf) of Baseline laboratory values and metastatic burden predict survival in addition to IMDC risk in real-world renal cell carcinoma patients treated with ipilimumab-nivolumab

Bronchoscopic intervention reduces dyspnea in severely symptomatic patients with central malignant airway obstruction

Svensson, Malin; Palm, Andreas; Westo, Nilla; Lindskog, Magnus

Part of Journal of Pain and Symptom Management, p. 38-45, 2025

• DOI for Bronchoscopic intervention reduces dyspnea in severely symptomatic patients with central malignant airway obstruction
• Download full text (pdf) of Bronchoscopic intervention reduces dyspnea in severely symptomatic patients with central malignant airway obstruction

Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer: a retrospective cohort study

Broström, Erika; Isaksson, Johan; Xanthoulis, Panagiotis; Börjesson, Rebecka et al.

Part of Translational Lung Cancer Research, p. 1972-1985, 2025

• DOI for Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer: a retrospective cohort study
• Download full text (pdf) of Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer: a retrospective cohort study

Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma

Braennbaeck, Anna; Mustonen, Ivan; Laajala, Teemu D.; Vainio, Paula et al.

Part of BJUI Compass, 2025

• DOI for Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma

Real-world drivers of treatment choices in synchronous metastatic renal cell carcinoma

Almdalal, Tarik; Fahlen, Maja; Harmenberg, Ulrika; Ljungberg, Borje et al.

Part of BJUI Compass, 2026

• DOI for Real-world drivers of treatment choices in synchronous metastatic renal cell carcinoma
• Download full text (pdf) of Real-world drivers of treatment choices in synchronous metastatic renal cell carcinoma

Baseline laboratory values and metastatic burden predict survival in addition to IMDC risk in real-world renal cell carcinoma patients treated with ipilimumab-nivolumab

Kheir, Alaa; Johannsdottir, Berglind; Gronn-Weiss, Alexandra; Liu, Lisa L. et al.

Part of Acta Oncologica, p. 1355-1364, 2025

• DOI for Baseline laboratory values and metastatic burden predict survival in addition to IMDC risk in real-world renal cell carcinoma patients treated with ipilimumab-nivolumab
• Download full text (pdf) of Baseline laboratory values and metastatic burden predict survival in addition to IMDC risk in real-world renal cell carcinoma patients treated with ipilimumab-nivolumab

Bronchoscopic intervention reduces dyspnea in severely symptomatic patients with central malignant airway obstruction

Svensson, Malin; Palm, Andreas; Westo, Nilla; Lindskog, Magnus

Part of Journal of Pain and Symptom Management, p. 38-45, 2025

• DOI for Bronchoscopic intervention reduces dyspnea in severely symptomatic patients with central malignant airway obstruction
• Download full text (pdf) of Bronchoscopic intervention reduces dyspnea in severely symptomatic patients with central malignant airway obstruction

Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer: a retrospective cohort study

Broström, Erika; Isaksson, Johan; Xanthoulis, Panagiotis; Börjesson, Rebecka et al.

Part of Translational Lung Cancer Research, p. 1972-1985, 2025

• DOI for Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer: a retrospective cohort study
• Download full text (pdf) of Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer: a retrospective cohort study

Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma

Braennbaeck, Anna; Mustonen, Ivan; Laajala, Teemu D.; Vainio, Paula et al.

Part of BJUI Compass, 2025

• DOI for Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma

The value of whole-body MRI instead of only brain MRI in addition to 18 F-FDG PET/CT in the staging of advanced non-small-cell lung cancer

Holmstrand, Hanna; Lindskog, Magnus; Sundin, Anders; Hansen, Tomas

Part of Cancer Imaging, 2025

• DOI for The value of whole-body MRI instead of only brain MRI in addition to 18 F-FDG PET/CT in the staging of advanced non-small-cell lung cancer
• Download full text (pdf) of The value of whole-body MRI instead of only brain MRI in addition to 18 F-FDG PET/CT in the staging of advanced non-small-cell lung cancer

Fluid therapy is associated with lower care quality and higher symptom burden during last days of life of patients with cancer: - a population-based register study

Lindskog, Magnus; Mogensen, Hanna; Tavelin, Bjoern; Eknert, Johanna et al.

Part of BMC Palliative Care, 2024

• DOI for Fluid therapy is associated with lower care quality and higher symptom burden during last days of life of patients with cancer: - a population-based register study
• Download full text (pdf) of Fluid therapy is associated with lower care quality and higher symptom burden during last days of life of patients with cancer: - a population-based register study

Immuno-oncological effects of standard anticancer agents and commonly used concomitant drugs: an in vitro assessment

Selvin, Tove; Berglund, Malin; Lenhammar, Lena; Lindskog, Magnus et al.

Part of BMC Pharmacology & Toxicology, 2024

• DOI for Immuno-oncological effects of standard anticancer agents and commonly used concomitant drugs: an in vitro assessment
• Download full text (pdf) of Immuno-oncological effects of standard anticancer agents and commonly used concomitant drugs: an in vitro assessment

Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical Trial

Werlenius, Katja; Kinhult, Sara; Solheim, Tora Skeidsvoll; Magelssen, Henriette et al.

Part of JAMA Network Open, 2023

• DOI for Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical Trial
• Download full text (pdf) of Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical Trial

Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature

Tsakonas, Georgios; Koulouris, Andreas; Kazmierczak, Dominika; Botling, Johan et al.

Part of International Journal of Molecular Sciences, 2023

• DOI for Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature
• Download full text (pdf) of Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature

Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study

Lindskog, Magnus; Laurell, Anna; Kjellman, Anders; Melichar, Bohuslav et al.

Part of European Urology Open Science, p. 38-45, 2022

• DOI for Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study
• Download full text (pdf) of Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study

Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease—A National Register Study

Almdalal, Tarik; Sundqvist, Pernilla; Harmenberg, Ulrika; Hellström, Mikael et al.

Part of European Urology Open Science, p. 22-28, 2022

• DOI for Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease—A National Register Study
• Download full text (pdf) of Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease—A National Register Study

Surgical waiting times and all-cause mortality in patients with non-metastatic renal cell carcinoma

Rosenblad, Andreas; Sundqvist, Pernilla; Harmenberg, Ulrika; Hellström, Mikael et al.

Part of Scandinavian journal of urology, p. 383-390, 2022

• DOI for Surgical waiting times and all-cause mortality in patients with non-metastatic renal cell carcinoma
• Download full text (pdf) of Surgical waiting times and all-cause mortality in patients with non-metastatic renal cell carcinoma

Acute healthcare utilization in end-of-life among Swedish brain tumor patients - a population based register study

Lindskog, Magnus; Schultz, Torbjorn; Strang, Peter

Part of BMC Palliative Care, 2022

• DOI for Acute healthcare utilization in end-of-life among Swedish brain tumor patients - a population based register study
• Download full text (pdf) of Acute healthcare utilization in end-of-life among Swedish brain tumor patients - a population based register study

Metastatic renal cell carcinoma to the brain: optimizing patient selection for gamma knife radiosurgery

Stenman, Maria; Benmakhlouf, H.; Wersäll, P.; Johnstone, P. et al.

Part of Acta Neurochirurgica, p. 333-342, 2021

• DOI for Metastatic renal cell carcinoma to the brain: optimizing patient selection for gamma knife radiosurgery

An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer

Tsakonas, Georgios; Lewensohn, Rolf; Botling, Johan; Ortiz-Villalon, Cristian et al.

Part of European Journal of Cancer, p. 24-34, 2020

• DOI for An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer
• Download full text (pdf) of An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer

Metastatic papillary renal cell carcinoma in the era of targeted therapy: a retrospective study from three European academic centres

Stenman, Maria; Staehler, Michael; Szabados, Bernadett; Sandström, Per et al.

Part of Acta Oncologica, p. 306-312, 2019

• DOI for Metastatic papillary renal cell carcinoma in the era of targeted therapy: a retrospective study from three European academic centres
• Download full text (pdf) of Metastatic papillary renal cell carcinoma in the era of targeted therapy: a retrospective study from three European academic centres

Cancer patients hospitalised in the last week of life risk insufficient care quality - a population-based study from the Swedish Register of Palliative Care

Elmstedt, Sixten; Mogensen, Hanna; Hallmans, Dan-Erik; Tavelin, Björn et al.

Part of Acta Oncologica, p. 432-438, 2019

• DOI for Cancer patients hospitalised in the last week of life risk insufficient care quality - a population-based study from the Swedish Register of Palliative Care
• Download full text (pdf) of Cancer patients hospitalised in the last week of life risk insufficient care quality - a population-based study from the Swedish Register of Palliative Care

Real-world cost-effectiveness of targeted therapy in metastatic renal cell carcinoma in Sweden: a population-based retrospective analysis

Redig, Josefine; Dalen, Johan; Harmenberg, Ulrika; Lindskog, Magnus et al.

Part of Cancer Management and Research, p. 1289-1297, 2019

• DOI for Real-world cost-effectiveness of targeted therapy in metastatic renal cell carcinoma in Sweden: a population-based retrospective analysis
• Download full text (pdf) of Real-world cost-effectiveness of targeted therapy in metastatic renal cell carcinoma in Sweden: a population-based retrospective analysis

Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial

Jakola, Asgeir Store; Werlenius, Katja; Mudaisi, Munila; Hylin, Sofia et al.

Part of F1000 Research, p. 1797, 2018

• DOI for Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial
• Download full text (pdf) of Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial

Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005-2014

Stenman, Maria; Sinclair, G.; Paavola, P.; Wersall, P. et al.

Part of Radiotherapy and Oncology, p. 501-506, 2018

• DOI for Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005-2014

Overall survival in Swedish patients with renal cell carcinoma treated in the period 2002 to 2012: Update of the RENCOMP study with subgroup analysis of the synchronous metastatic and elderly populations

Lindskog, Magnus; Wahlgren, Thomas; Sandin, Rickard; Kowalski, Jan et al.

Part of Urologic Oncology, 2017

• DOI for Overall survival in Swedish patients with renal cell carcinoma treated in the period 2002 to 2012: Update of the RENCOMP study with subgroup analysis of the synchronous metastatic and elderly populations

Heed or disregard a cancer patient's critical blogging?: An experimental study of two different framing strategies

Lynoe, Niels; NattochDag, Sara; Lindskog, Magnus; Juth, Niklas

Part of BMC Medical Ethics, 2016

• DOI for Heed or disregard a cancer patient's critical blogging?: An experimental study of two different framing strategies
• Download full text (pdf) of Heed or disregard a cancer patient's critical blogging?: An experimental study of two different framing strategies

Metastatic papillary renal cell carcinoma: A retrospective study from two large academic centers in Sweden

Stenman, Maria; Nearchou, Andreas Demetrios; Sandström, Per; Lindskog, Magnus et al.

Part of Journal of Clinical Oncology, 2016

Old age as risk indicator for poor end-of-life care quality - A population-based study of cancer deaths from the Swedish Register of Palliative Care

Lindskog, Magnus; Tavelin, Bjorn; Lundstrom, Staffan

Part of European Journal of Cancer, p. 1331-1339, 2015

• DOI for Old age as risk indicator for poor end-of-life care quality - A population-based study of cancer deaths from the Swedish Register of Palliative Care

Overall survival (OS) in Swedish RCC patients treated 2000-2012: Update of the RENCOMP study

Lindskog, Magnus; Wahlgren, Thomas; Sandin, Rickard; Kowalski, Jan et al.

Part of Journal of Clinical Oncology, 2015

Prognostic significance of serum albumin in patients with metastatic renal cell carcinoma

Stenman, Maria; Laurell, Anna; Lindskog, Magnus

Part of Medical Oncology, p. 841, 2014

• DOI for Prognostic significance of serum albumin in patients with metastatic renal cell carcinoma

Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy

Sörenson, S.; Fohlin, H.; Lindgren, A.; Lindskog, Magnus et al.

Part of European Journal of Cancer, p. 115-120, 2013

• DOI for Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy

Omega-3 from fish oil augments GVHD through the enhancement of chemotherapy conditioning regimen and selective FoxP3 depletion

Al Hashmi, S.; Sadeghi, B.; Hassan, Z.; Abedi-Valugerdi, M. et al.

Part of Bone Marrow Transplantation, p. 843-848, 2013

• DOI for Omega-3 from fish oil augments GVHD through the enhancement of chemotherapy conditioning regimen and selective FoxP3 depletion

Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo

Gleissman, Helena; Segerström, Lova; Hamberg, Mats; Ponthan, Frida et al.

Part of International Journal of Cancer, p. 1703-1711, 2011

• DOI for Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo

Fish oil delays lymphoma progression in the TLL mouse

Johansson, Ann-Sofie; Norén-Nyström, Ulrika; Larefalk, Åsa; Holmberg, Dan et al.

Part of Leukemia and Lymphoma, p. 2092-2097, 2010

• DOI for Fish oil delays lymphoma progression in the TLL mouse

Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs

Felth, Jenny; Rickardson, Linda; Rosén, Josefin; Wickström, Malin et al.

Part of Journal of natural products (Print), p. 1969-1974, 2009

• DOI for Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs

Lymphoblastic T-cell lymphoma in mice is unaffected by Celecoxib as single agent or in combination with cyclophosphamide

Johansson, Ann-Sofie; Pawelzik, Sven-Christian; Larefalk, Åsa; Jakobsson, Per-Johan et al.

Part of Leukemia and Lymphoma, p. 1198-1203, 2009

• DOI for Lymphoblastic T-cell lymphoma in mice is unaffected by Celecoxib as single agent or in combination with cyclophosphamide

The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo

Wickström, Malin; Johnsen, John Inge; Ponthan, Frida; Segerström, Lova et al.

Part of Molecular Cancer Therapeutics, p. 2409-2417, 2007

• DOI for The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo

Glycaemic control in end-of-life care: fundamental or futile?

Lindskog, Magnus; Karvestedt, Lars; Furst, Carl Johan

Part of Current Opinion in Supportive and Palliative Care, p. 378-382, 2014

• DOI for Glycaemic control in end-of-life care: fundamental or futile?

Albumin, corticosteroid use and Karnofsky performance status predict outcome of single-fraction gamma knife radiosurgery in clear cell renal cell carcinoma patients with brain metastases

Stenman, Maria; Benmakhlouf, Hamza; Wersäll, Peter; Hatiboglu, Mustafa Aziz et al.

Survival prediction in locally advanced non-small cell lung cancer using supervoxel-based longitudinal analysis of whole-body [¹⁸F]FDG PET/CT

Jönsson, Hanna; Holmstrand, Hanna; Öfverstedt, Johan; Hansen, Tomas et al.